TransMedics Announces Publication Of OCS™ Liver PROTECT Trial Results In JAMA Surgery [TheStreet.com]
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: TheStreet.com
that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the publication of OCS™ Liver PROTECT Trial Results in JAMA Surgery, a member of the Journal of the American Medical Association (JAMA) Network. The publication, titled, was published online on January 5, 2022. The OCS™ Liver System was approved by the U.S. Food and Drug Administration (FDA) for the preservation and assessment of donor livers for transplant from donors after brain death (DBD) and after circulatory death (DCD) on September 29, 2021. "The PROTECT trial showed superior short-term and mid-term clinical outcomes and higher numbers of donor livers used for transplant," said Dr. James F. Markmann, Chief of the Division of Transplantation Surgery at Massachusetts General Hospital and the lead author of the manuscript. "We concluded, that the advent of portable, extracorporeal, donor liver machine perfusion offers for the first time a convenient and effect
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024PR Newswire
- TransMedics (TMDX) Flat As Market Sinks: What You Should Know [Yahoo! Finance]Yahoo! Finance
- There's Been No Shortage Of Growth Recently For TransMedics Group's (NASDAQ:TMDX) Returns On Capital [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store? [Yahoo! Finance]Yahoo! Finance
- How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings [Yahoo! Finance]Yahoo! Finance
TMDX
Earnings
- 2/26/24 - Beat
TMDX
Sec Filings
- 4/18/24 - Form 4
- 4/12/24 - Form 4
- 4/10/24 - Form 4
- TMDX's page on the SEC website